proxyvotesnow.com

Home › Companies › SUMMIT THERAPEUTICS INC. › 2024-2025

SUMMIT THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and SUMMIT THERAPEUTICS INC.’s Form 8-K, filed 2025-06-17 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 11Ballot items
  • 224Asset managers
  • 2,631Fund votes
  • 2025-06-12Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore SUMMIT THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by SUMMIT THERAPEUTICS INC.

These tallies are SUMMIT THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

SUMMIT THERAPEUTICS INC. — official shareholder meeting results, meeting held 2025-06-12
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Robert W. Duggan 613,045,226---- 26,69229,651,787 Majority: yes
Elect Director: Mahkam Zanganeh 613,581,910---- 37,54629,651,787 Majority: yes
Elect Director: Manmeet Soni 611,431,814---- 52,32629,651,787 Majority: yes
Elect Director: Kenneth A. Clark 605,079,891---- 51,55829,651,787 Majority: yes
Elect Director: Robert Booth 623,298,472---- 55,31929,651,787 Majority: yes
Elect Director: Alessandra Cesano 617,638,155---- 54,44329,651,787 Majority: yes
Elect Director: Yu (Michelle) Xia 610,437,122---- 54,39629,651,787 Majority: yes
Elect Director: Mostafa Ronaghi 620,904,380---- 54,32429,651,787 Majority: yes
Elect Director: Jeff Huber 623,664,686---- 53,33029,651,787 Majority: yes
Elect Director: Ratification of the appointment of PricewaterhouseCoopers LLP 653,328,708195,007233,629 ---- Majority: yes
Elect Director: Advisory vote to approve the compensation of named executive officers 607,320,35316,607,648177,556 --29,651,787 Majority: yes

Source: SUMMIT THERAPEUTICS INC., Form 8-K, filed with the SEC on 2025-06-17 — read the filing on EDGAR.

How asset managers voted at the SUMMIT THERAPEUTICS INC. 2024-2025 meeting

Each item below shows how the 224 asset managers that disclosed a SUMMIT THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Approval, by a non-binding advisory vote, of the compensation of our named executive officers.

COMPENSATIONMajority of the votes cast: yes

Combines 11 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 607,320,353AGAINST: 16,607,648

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Advisory vote to approve the compensation of named executive officers”): 607,320,353 for, 16,607,648 against, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 82% for, 2% against (84% of the company cast a for/against vote).

The 223 asset managers below cast 37% of the shares they voted on this item FOR (13,585,444 for, 22,683,705 against).

FOR 37%AGAINST 63%
FOR: 13,585,444 (37.5%)AGAINST: 22,683,705 (62.5%)ABSTAIN: 3,863 (0.0%)NOT VOTED: 335 (0.0%)
Largest asset managers voting on “Approval, by a non-binding advisory vote, of the compensation of our named executive officers.” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price09,776,357 00Against
Fidelity66,3723,982,302 00Against
Vanguard3,864,0865,299 00For
Charles Schwab2,501,8470 00For
Aberdeen02,401,620 00Against
PICTET ASSET MANAGEMENT SA02,324,786 00Against
BlackRock1,832,80633,892 00For
State Street1,467,1807,264 00For
ROCKLAND TRUST CO800,0000 00For
Rock Springs Capital Management LP0570,994 00Against
Northern Trust472,6120 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.464,1350 00For
Putnam0416,646 00Against
Russell Investments314,9080 00For
JPMorgan0273,869 00Against
Point720235,502 00Against
Lincoln Financial67,900155,836 00Against
Ensign Peak Advisors, Inc220,7330 00For
Allianz0211,625 00Against
Citadel189,5070 00For
BANK OF AMERICA NA184,6400 00For
BANK OF MONTREAL /CAN/856179,414 00Against
PRINCIPAL GLOBAL INVESTORS0171,289 00Against
MELLON INVESTMENTS Corp0148,574 00Against
BALYASNY ASSET MANAGEMENT L.P.123,4650 00For

Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.

2. ELECTION OF DIRECTORS: Alessandra Cesano

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 617,638,155WITHHELD: 54,443

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alessandra Cesano”): 617,638,155 for, 54,443 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 83% for, 0.1% withheld (83% of the company cast a for/withheld vote).

The 59 asset managers below cast 69% of the shares they voted on this item FOR (9,888,214 for, 4,534,823 against).

FOR 69%AGAINST 31%
FOR: 9,888,214 (68.5%)AGAINST: 4,534,823 (31.4%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Alessandra Cesano” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price4,400,6700 00For
Vanguard8033,701,082 00Against
Fidelity1,300,3950 00For
Charles Schwab1,250,3410 00For
Aberdeen1,200,8100 00For
BlackRock0725,530 00Against
State Street228,82865 00For
Lincoln Financial223,7360 00For
Putnam169,6730 00For
Equitable100,62714,710 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock87,5030 00For
Calamos72,8440 00For
Direxion Shares ETF Trust70,4170 00For
OPTIMUM FUND TRUST67,4410 00For
Principal Exchange-Traded Funds61,7220 00For
AQR60,8150 00For
ProShares50,7500 00For
TIAA47,7900 00For
AIG/SunAmerica47,2620 00For
Northern Trust42,5630 00For
Pacific Life030,452 00Against
Brighthouse24,7220 3,8400For
Global X23,8340 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

3. ELECTION OF DIRECTORS: Jeff Huber

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 623,664,686WITHHELD: 53,330

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Jeff Huber”): 623,664,686 for, 53,330 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 84% for, 0.1% withheld (84% of the company cast a for/withheld vote).

The 59 asset managers below cast 99.8% of the shares they voted on this item FOR (14,399,857 for, 23,180 against).

FOR 99.8%
FOR: 14,399,857 (99.8%)AGAINST: 23,180 (0.2%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Jeff Huber” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price4,400,6700 00For
Vanguard3,701,117768 00For
Fidelity1,300,3950 00For
Charles Schwab1,250,3410 00For
Aberdeen1,200,8100 00For
BlackRock725,5300 00For
State Street228,82865 00For
Lincoln Financial223,7360 00For
Putnam169,6730 00For
Equitable115,3370 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock87,5030 00For
Calamos72,8440 00For
Direxion Shares ETF Trust70,4170 00For
OPTIMUM FUND TRUST67,4410 00For
Principal Exchange-Traded Funds61,7220 00For
AQR60,8150 00For
ProShares50,7500 00For
TIAA47,7900 00For
AIG/SunAmerica47,2620 00For
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse24,7220 3,8400For
Global X23,8340 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

4. ELECTION OF DIRECTORS: Kenneth A. Clark

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 605,079,891WITHHELD: 51,558

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth A. Clark”): 605,079,891 for, 51,558 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 82% for, 0.1% withheld (82% of the company cast a for/withheld vote).

The 59 asset managers below cast 33% of the shares they voted on this item FOR (4,750,781 for, 9,672,255 against).

FOR 33%AGAINST 67%
FOR: 4,750,781 (32.9%)AGAINST: 9,672,255 (67.0%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Kenneth A. Clark” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price04,400,670 00Against
Vanguard3,701,117768 00For
Fidelity66,3721,234,023 00Against
Charles Schwab4531,249,888 00Against
Aberdeen01,200,810 00Against
BlackRock422,891302,639 00For
State Street642228,251 00Against
Lincoln Financial0223,736 00Against
Putnam169,6730 00For
Equitable14,710100,627 00Against
Russell Investments0106,900 00Against
Tema ETF Trust99,2150 00For
John Hancock087,503 00Against
Calamos72,8440 00For
Direxion Shares ETF Trust070,417 00Against
OPTIMUM FUND TRUST067,441 00Against
Principal Exchange-Traded Funds061,722 00Against
AQR060,815 00Against
ProShares050,750 00Against
TIAA47,7900 00For
AIG/SunAmerica047,262 00Against
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse024,722 3,8400Against
Global X023,834 00Against

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

5. ELECTION OF DIRECTORS: Mahkam Zanganeh

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 613,581,910WITHHELD: 37,546

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mahkam Zanganeh”): 613,581,910 for, 37,546 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 83% for, 0.1% withheld (83% of the company cast a for/withheld vote).

The 59 asset managers below cast 65% of the shares they voted on this item FOR (9,318,420 for, 5,104,617 against).

FOR 65%AGAINST 35%
FOR: 9,318,420 (64.6%)AGAINST: 5,104,617 (35.4%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Mahkam Zanganeh” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price04,400,670 00Against
Vanguard3,701,8850 00For
Fidelity1,300,3950 00For
Charles Schwab1,250,3410 00For
Aberdeen1,200,8100 00For
BlackRock725,5300 00For
State Street228,605288 00For
Lincoln Financial67,900155,836 00Against
Putnam169,6730 00For
Equitable107,4407,897 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock087,503 00Against
Calamos72,8440 00For
Direxion Shares ETF Trust070,417 00Against
OPTIMUM FUND TRUST067,441 00Against
Principal Exchange-Traded Funds061,722 00Against
AQR060,815 00Against
ProShares050,750 00Against
TIAA47,7900 00For
AIG/SunAmerica047,262 00Against
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse024,722 3,8400Against
Global X23,8340 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

6. ELECTION OF DIRECTORS: Manmeet S. Soni

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 611,431,814WITHHELD: 52,326

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Manmeet Soni”): 611,431,814 for, 52,326 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 82% for, 0.1% withheld (82% of the company cast a for/withheld vote).

The 59 asset managers below cast 62% of the shares they voted on this item FOR (8,963,239 for, 5,459,798 against).

FOR 62%AGAINST 38%
FOR: 8,963,239 (62.1%)AGAINST: 5,459,798 (37.8%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Manmeet S. Soni” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price04,400,670 00Against
Vanguard3,701,117768 00For
Fidelity1,300,3950 00For
Charles Schwab1,250,201139 00For
Aberdeen1,200,8100 00For
BlackRock725,5300 00For
State Street642228,251 00Against
Lincoln Financial0223,736 00Against
Putnam169,6730 00For
Equitable107,4407,897 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock087,503 00Against
Calamos72,8440 00For
Direxion Shares ETF Trust070,417 00Against
OPTIMUM FUND TRUST067,441 00Against
Principal Exchange-Traded Funds061,722 00Against
AQR060,815 00Against
ProShares050,750 00Against
TIAA47,7900 00For
AIG/SunAmerica047,262 00Against
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse024,722 3,8400Against
Global X023,834 00Against

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

7. ELECTION OF DIRECTORS: Mostafa Ronaghi

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 620,904,380WITHHELD: 54,324

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Mostafa Ronaghi”): 620,904,380 for, 54,324 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 84% for, 0.1% withheld (84% of the company cast a for/withheld vote).

The 59 asset managers below cast 91% of the shares they voted on this item FOR (13,165,834 for, 1,257,203 against).

FOR 91%9%
FOR: 13,165,834 (91.3%)AGAINST: 1,257,203 (8.7%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Mostafa Ronaghi” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price4,400,6700 00For
Vanguard3,701,117768 00For
Fidelity66,3721,234,023 00Against
Charles Schwab1,250,3410 00For
Aberdeen1,200,8100 00For
BlackRock725,5300 00For
State Street228,82865 00For
Lincoln Financial223,7360 00For
Putnam169,6730 00For
Equitable115,3370 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock87,5030 00For
Calamos72,8440 00For
Direxion Shares ETF Trust70,4170 00For
OPTIMUM FUND TRUST67,4410 00For
Principal Exchange-Traded Funds61,7220 00For
AQR60,8150 00For
ProShares50,7500 00For
TIAA47,7900 00For
AIG/SunAmerica47,2620 00For
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse24,7220 3,8400For
Global X23,8340 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

8. ELECTION OF DIRECTORS: Robert Booth

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 623,298,472WITHHELD: 55,319

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert Booth”): 623,298,472 for, 55,319 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 84% for, 0.1% withheld (84% of the company cast a for/withheld vote).

The 59 asset managers below cast 99.8% of the shares they voted on this item FOR (14,397,197 for, 25,840 against).

FOR 99.7%
FOR: 14,397,197 (99.8%)AGAINST: 25,840 (0.2%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Robert Booth” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price4,400,6700 00For
Vanguard3,701,117768 00For
Fidelity1,300,3950 00For
Charles Schwab1,250,3410 00For
Aberdeen1,200,8100 00For
BlackRock725,5300 00For
State Street228,82865 00For
Lincoln Financial223,7360 00For
Putnam169,6730 00For
Equitable115,3370 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock87,5030 00For
Calamos72,8440 00For
Direxion Shares ETF Trust70,4170 00For
OPTIMUM FUND TRUST67,4410 00For
Principal Exchange-Traded Funds61,7220 00For
AQR60,8150 00For
ProShares50,7500 00For
TIAA47,7900 00For
AIG/SunAmerica47,2620 00For
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse24,7220 3,8400For
Global X23,8340 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

9. ELECTION OF DIRECTORS: Robert W. Duggan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 613,045,226WITHHELD: 26,692

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert W. Duggan”): 613,045,226 for, 26,692 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 83% for, 0.1% withheld (83% of the company cast a for/withheld vote).

The 59 asset managers below cast 64% of the shares they voted on this item FOR (9,301,747 for, 5,121,290 against).

FOR 64%AGAINST 35%
FOR: 9,301,747 (64.5%)AGAINST: 5,121,290 (35.5%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Robert W. Duggan” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price04,400,670 00Against
Vanguard3,701,8850 00For
Fidelity1,300,3950 00For
Charles Schwab1,250,3410 00For
Aberdeen1,200,8100 00For
BlackRock725,5300 00For
State Street228,605288 00For
Lincoln Financial67,900155,836 00Against
Putnam169,6730 00For
Equitable107,4407,897 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock087,503 00Against
Calamos72,8440 00For
Direxion Shares ETF Trust070,417 00Against
OPTIMUM FUND TRUST067,441 00Against
Principal Exchange-Traded Funds061,722 00Against
AQR060,815 00Against
ProShares050,750 00Against
TIAA47,7900 00For
AIG/SunAmerica047,262 00Against
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse024,722 3,8400Against
Global X23,8340 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

10. ELECTION OF DIRECTORS: Yu (Michelle) Xia

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 610,437,122WITHHELD: 54,396

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yu (Michelle) Xia”): 610,437,122 for, 54,396 withheld, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 82% for, 0.1% withheld (82% of the company cast a for/withheld vote).

The 59 asset managers below cast 54.1% of the shares they voted on this item FOR (7,800,244 for, 6,622,793 against).

FOR 54.1%AGAINST 45.9%
FOR: 7,800,244 (54.1%)AGAINST: 6,622,793 (45.9%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTORS: Yu (Michelle) Xia” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price04,400,670 00Against
Vanguard3,701,8850 00For
Fidelity1,300,3950 00For
Charles Schwab1,250,3410 00For
Aberdeen01,200,810 00Against
BlackRock725,5300 00For
State Street642228,251 00Against
Lincoln Financial0223,736 00Against
Putnam169,6730 00For
Equitable107,4407,897 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock087,503 00Against
Calamos72,8440 00For
Direxion Shares ETF Trust070,417 00Against
OPTIMUM FUND TRUST067,441 00Against
Principal Exchange-Traded Funds061,722 00Against
AQR060,815 00Against
ProShares050,750 00Against
TIAA47,7900 00For
AIG/SunAmerica047,262 00Against
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse024,722 3,8400Against
Global X23,8340 00For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

11. Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 653,328,708AGAINST: 195,007

SUMMIT THERAPEUTICS INC.’s own tally for this item (“Elect Director: Ratification of the appointment of PricewaterhouseCoopers LLP”): 653,328,708 for, 195,007 against, per its Form 8-K filed 2025-06-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 741,609,390 outstanding shares: 88% for, 0.1% against (88% of the company cast a for/against vote).

The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (14,419,210 for, 478 against).

FOR 99.9%
FOR: 14,419,210 (100.0%)AGAINST: 478 (0.0%)ABSTAIN: 3,840 (0.0%)NOT VOTED: 72 (0.0%)
Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accounting Firm” at SUMMIT THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price4,400,6700 00For
Vanguard3,701,8850 00For
Fidelity1,300,3950 00For
Charles Schwab1,250,3410 00For
Aberdeen1,200,8100 00For
BlackRock725,5300 00For
State Street228,8930 00For
Lincoln Financial223,7360 00For
Putnam169,6730 00For
Equitable115,3370 00For
Russell Investments106,9000 00For
Tema ETF Trust99,2150 00For
John Hancock87,5030 00For
Calamos72,8440 00For
Direxion Shares ETF Trust70,4170 00For
OPTIMUM FUND TRUST67,4410 00For
Principal Exchange-Traded Funds61,7220 00For
AQR60,8150 00For
ProShares50,7500 00For
TIAA47,7900 00For
AIG/SunAmerica47,2620 00For
Northern Trust42,5630 00For
Pacific Life30,4520 00For
Brighthouse24,7220 3,8400For
Global X23,8340 00For

Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.

Largest SUMMIT THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked by the number of SUMMIT THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 741,609,390 shares outstanding at the time of that meeting.

Top SUMMIT THERAPEUTICS INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1T. Rowe Price 1.32%
2Fidelity 0.55%
3Vanguard 0.52%
4Charles Schwab 0.34%
5Aberdeen 0.32%
6PICTET ASSET MANAGEMENT SA 0.31%
7BlackRock 0.25%
8State Street 0.20%
9ROCKLAND TRUST CO 0.11%
10Rock Springs Capital Management LP 0.08%

Reported SUMMIT THERAPEUTICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

SUMMIT THERAPEUTICS INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Robert W. Duggan 74.93% DEF14A
Mahkam Zanganeh 4.82% DEF14A
Yu (Michelle) Xia 4.25% DEF14A
Vanguard Group 1.57% 13F
FMR (Fidelity) 1.26% 13F
BlackRock 1.13% 13F
T. Rowe Price 0.88% 13F
State Street 0.65% 13F
Geode Capital 0.44% 13F
Manmeet Soni 0.41% DEF14A

Percentages above are of 741,609,390 shares outstanding, as reported by SUMMIT THERAPEUTICS INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from SUMMIT THERAPEUTICS INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At SUMMIT THERAPEUTICS INC.'s shareholder meeting held 2025-06-12, in the 2024-2025 proxy season, 224 asset managers reported how they voted on 11 ballot items in their SEC Form N-PX filings, covering 2,631 separate fund positions. On the most widely held item on that ballot — Approval, by a non-binding advisory vote, of the compensation of our named executive officers. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: SUMMIT THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-17.

SUMMIT THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.